Literature DB >> 7997431

Hyperuricemia in an infant with Taussig-Bing anomaly and interruption of the aortic arch.

Y Hayabuchi1, S Matsuoka, Y Takahashi, H Akita, T Kitagawa, I Kato, Y Kuroda.   

Abstract

Hyperuricemia is commonly recognized in adolescents and adults with cyanotic congenital heart disease. We report a case of a male infant with hyperuricemia, Taussig-Bing anomaly, and interruption of the aortic arch. The patient underwent correction of interrupted aortic arch and pulmonary arterial banding at the age of 7 days. Hyperuricemia appeared when he was 2 months old (max 17.7 mg/dl) and persisted until he underwent a Jatene operation at the age of 10 months. The hyperuricemia improved gradually after the disappearance of hypoxia and polycythemia. The laboratory findings suggest that hyperuricemia can result from uric acid overproduction due to secondary polycythemia, impairment of uric acid excretion by the kidney, or the acceleration of anaerobic metabolism. Allopurinol and benzbromarone together were partially effective treatments for hyperuricemia in this patient with cyanotic congenital heart disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7997431     DOI: 10.1007/BF00795737

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  GOUT IN CYANOTIC CONGENITAL HEART DISEASE.

Authors:  J Somerville
Journal:  Br Heart J       Date:  1961-01

2.  Glomerulomegaly in a patient with cyanotic congenital heart disease.

Authors:  J R Ingelfinger; J M Kissane; A M Robson
Journal:  Am J Dis Child       Date:  1970-07

3.  Hyperuricemia in cyanotic congenital heart disease.

Authors:  D Young
Journal:  Am J Dis Child       Date:  1980-09

Review 4.  Adults with cyanotic congenital heart disease: hematologic management.

Authors:  J K Perloff; M H Rosove; J S Child; G B Wright
Journal:  Ann Intern Med       Date:  1988-09-01       Impact factor: 25.391

5.  Abnormal renal functions in cyanotic congential heart disease.

Authors:  J Passwell; S Orda; M Modan; A Shem-Tov; A Aladjem; H Boichis
Journal:  Arch Dis Child       Date:  1976-10       Impact factor: 3.791

6.  Nephropathy in cyanotic congenital heart disease.

Authors:  J R Burke; E F Glasgow; D A McCredie; H R Powell
Journal:  Clin Nephrol       Date:  1977-01       Impact factor: 0.975

7.  Renal function in children undergoing cardiac operations.

Authors:  E N Ellis; B H Brouhard; V R Conti
Journal:  Ann Thorac Surg       Date:  1983-08       Impact factor: 4.330

8.  Renal function and urate metabolism in late survivors with cyanotic congenital heart disease.

Authors:  E A Ross; J K Perloff; G M Danovitch; J S Child; M M Canobbio
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

9.  Hyperuricemia in congenital heart disease.

Authors:  J C Dearth; R B Tompkins; E R Giuliani; R H Feldt
Journal:  Am J Dis Child       Date:  1978-09

10.  Impairment of urate excretion in patients with cardiac disease.

Authors:  S E Mace; A J Newman; J Liebman
Journal:  Am J Dis Child       Date:  1984-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.